🇺🇸 FDA
Patent

US 7326712

Substituted tricyclic compounds as protein kinase inhibitors

granted A61PA61P35/00A61P35/04

Quick answer

US patent 7326712 (Substituted tricyclic compounds as protein kinase inhibitors) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P35/00, A61P35/04, A61P43/00